FIELD: chemistry.
SUBSTANCE: present invention relates to compounds of formula (I), wherein residues R1-R5, V, G and M are as defined in the claims. Compounds by the present invention are effective platelet (GPR92) LPAR5 receptor antagonists, and they can generally be used in diseases, at which there is undesirable activation of LPA receptor LPAR5 platelets, LPA receptor LPAR5 mast cells or LPA receptor LPAR5 cells of microglia or for treatment or prevention of which inhibition of LPA receptor of platelet LPAR5, mast cells or microglial cells is expected. Moreover, present invention relates to methods for preparation of compounds of formula (I), their use, in particular as active ingredients in drugs, and to pharmaceutical compositions containing them.
.
EFFECT: compounds of formula (I) are valuable pharmacologically active compounds for use in the treatment of various diseases, such as cardiovascular disease, like thromboembolic disease or restenosis.
9 cl, 3 tbl, 28 ex
Title | Year | Author | Number |
---|---|---|---|
BENZO[1,3]DIOXIN DERIVATIVES AND THEIR USE AS LPAR5 ANTAGONISTS | 2013 |
|
RU2647727C2 |
N-(4-(AZAINDAZOL-6-IL)-PHENYL)-SULFONAMIDES AND THEIR USE AS DRUGS | 2014 |
|
RU2671864C2 |
AMINO-SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND USE THEREOF AS PHARMACEUTICAL AGENTS | 2012 |
|
RU2605600C2 |
SUBSTITUTED DERIVATIVES OF 3-HETEROAROYLAMINOPROPIONIC ACID AND THEIR APPLICATION AS DRUGS | 2012 |
|
RU2632897C2 |
SUBSTITUTED CHROMAN-6-YLOXY-CYCLOALKANES AND USE THEREOF AS MEDICAMENTS | 2014 |
|
RU2666350C2 |
8-CARBAMOYL-2-(2,3-DI-SUBSTITUTED PYRID-6-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE DERIVATIVES AS APOPTOSIS-INDUCING AGENTS FOR CANCER TREATMENT | 2012 |
|
RU2625315C2 |
CONDENSED PYRIMIDINE COMPOUND OR SALT THEREOF | 2016 |
|
RU2729636C2 |
FUSED PYRROLEDICARBOXAMIDES AND THEIR USE AS PHARMACEUTICALS | 2013 |
|
RU2650111C2 |
NEW BICYCLIC PYRAZOLE DERIVATIVES | 2018 |
|
RU2781426C2 |
CONDENSED TRICYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2700004C1 |
Authors
Dates
2018-02-21—Published
2013-05-16—Filed